Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANRS HB 06 PEGAN
2010-019367-11Phase 3Active
- Sponsor
- ANRS
- Start
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of peginterferon alfa-2a in Chronic hepatitis B (CHB), sponsored by ANRS. Primary endpoint: HBsAg loss at week 96. Started Jul 2010; status: active.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic hepatitis B (CHB)
Beyond the preview
Go deeper on 2010-019367-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019367-11.